Gentherm二季度收入4.16亿美元并上调2026年指引、授权4亿美元回购

Google raises annual spending estimates amid rapid AI infrastructure build-out
Introduction & Market Context
Gentherm (NASDAQ:THRM) presented its second quarter 2026 results on July 23, showcasing record quarterly revenue and raising its full-year guidance despite persistent margin pressures. The automotive thermal management specialist reported product revenues of $416 million, representing 9.5% growth excluding foreign exchange effects, significantly outpacing a declining light vehicle production environment.
The company’s stock traded at $36.01 in premarket activity, near the upper end of its 52-week range of $27.00 to $39.48, reflecting investor confidence in the company’s growth trajectory and pending strategic combination with Modine Performance Technologies.
Quarterly Performance Highlights
The company’s second quarter results demonstrated broad-based strength across its automotive climate and comfort solutions portfolio. As shown in the following performance summary, Gentherm achieved several key milestones during the quarter:
Automotive new business awards totaled $690 million in the quarter, bringing year-to-date awards to more than $1 billion. This robust order intake underscores the company’s competitive positioning and product innovation in heated and ventilated seating, steering wheel heating, and comfort solutions.
The company’s automotive climate and comfort solutions grew 12.7% year-over-year on a constant currency basis, with particularly strong performance in China driven by new domestic program launches and increased adoption rates among global customers. Lumbar and massage comfort solutions posted 38% growth compared to the prior year period.
Detailed Financial Analysis
Gentherm’s financial performance in the second quarter reflected strong operational execution tempered by anticipated headwinds. The following detailed breakdown illustrates the company’s revenue growth, profitability metrics, and cash generation:
Product revenues reached $416 million, up from $375 million in the second quarter of 2025. Adjusted EBITDA totaled $48.8 million, or 11.7% of revenues, compared to $45.9 million and 12.2% margin in the prior year period. The 50 basis point margin decline reflected timing of inflation recovery, planned inventory reductions tied to footprint optimization, and higher warranty accruals in both automotive and medical segments.
Year-to-date adjusted free cash flow of $16 million was $5 million below the prior year, though liquidity strengthened to $502 million, an increase of $86 million year-over-year. The company maintained a conservative net leverage ratio of approximately 0.3x.
Capital expenditures declined to $14.2 million in the quarter, down $9.5 million from the prior year, reflecting continued focus on asset utilization and capital discipline.
The company’s complete income statement data reveals the underlying drivers of performance:
Automotive revenues of $404.8 million represented the vast majority of total product revenues, while medical revenues contributed $11.4 million. Operating expenses increased to $85.7 million from $65.8 million in the prior year, primarily due to merger and acquisition expenses related to the pending Modine transaction.
Balance sheet strength remained robust, as illustrated by the following key metrics:
Cash and cash equivalents increased to $213.2 million from $160.8 million at year-end 2025, while total debt rose to $273.3 million from $189.1 million, reflecting financing activities related to strategic initiatives.
The company provided detailed reconciliations of its non-GAAP metrics, demonstrating transparency in financial reporting:
Strategic Combination with Modine Performance Technologies
The transformative merger with Modine Performance Technologies remains on track for an early fourth quarter 2026 closing, representing a pivotal strategic shift for Gentherm. The combination will fundamentally reshape the company’s business mix and market exposure:
The transaction will reduce Gentherm’s light vehicle revenue concentration from 97% to approximately 63%, while providing entry into attractive growth markets including commercial vehicles, off-highway equipment, and power generation. The combined company projects near-term cost synergies of approximately $25 million and has identified more than $100 million in commercial opportunities through cross-selling, product integration, and geographic expansion.
On a pro forma basis, the combined entity would have generated $2.6 billion in revenue based on last-twelve-months September 2025 figures, with adjusted EBITDA of $322 million representing approximately 12% margins. By 2030, management targets revenue exceeding $3.5 billion with adjusted EBITDA margins of 15% or higher.
The transaction timeline shows steady progress toward completion:
Key milestones achieved include U.S. regulatory approval through Hart-Scott-Rodino clearance, completion of audited carve-out financials, secured financing, and S-4/proxy filings. The company expects to obtain ex-U.S. regulatory approvals, U.S. tax rulings, and shareholder approval before the anticipated early fourth quarter closing.
Strategic Initiatives
Beyond the Modine combination, Gentherm is executing a multi-pronged growth strategy targeting adjacent markets. The company’s strategic framework emphasizes four key pillars supporting total shareholder return:
In the medical segment, Gentherm received FDA clearance for ThermAffyx, a thermal management and securement product, with initial commercial launch underway. The company also completed its acquisition of Innovative Medical Equipment (IME), which expands its thermal management portfolio and sales channels. The IME acquisition, completed for $34 million, is expected to contribute approximately $17 million in full-year 2026 revenue.
The company has also made significant progress in home and office applications, winning contracts with leading North American furniture brands for the fourth consecutive quarter. Management now projects $50 million to $100 million in revenue from this channel by 2028, representing a meaningful diversification opportunity.
Financial Position and Capital Allocation
Gentherm’s strengthened financial position supports a balanced capital allocation strategy focused on organic investment, shareholder returns, and strategic M&A:
The company’s board of directors authorized a new $400 million stock repurchase program, nearly triple the size of the previous $150 million authorization. Management expects to begin repurchasing shares following the close of the Modine transaction.
Post-closing, the combined company is projected to maintain a net leverage ratio of approximately 1.0x, with a target range of 1.0x to 1.5x over time. The company forecasts more than $1 billion in adjusted unlevered free cash flow generation through 2030, providing substantial financial flexibility for growth investments and shareholder returns.
Forward-Looking Statements and Guidance
Based on strong first-half performance, Gentherm raised its full-year 2026 guidance across all key metrics:
Product revenues are now expected in the range of $1.55 billion to $1.65 billion, representing approximately 5% growth year-over-year on a constant currency basis. This outlook assumes light vehicle production declining at approximately 3% for the full year, implying continued mid-to-high single-digit outperformance versus the market.
Adjusted EBITDA guidance of $185 million to $200 million represents approximately 12% of product revenues at the midpoint, with margin expansion of roughly 30 basis points year-over-year. The company noted that footprint optimization activities represent approximately 60 basis points of margin headwind, which management expects to mitigate through customer price recovery and operational efficiency improvements.
Adjusted free cash flow is projected at $85 million to $100 million, with capital expenditures trending toward the lower end of the $45 million to $55 million range. This implies an adjusted free cash flow conversion rate of approximately 50%.
Management maintained its confidence in achieving at least $1.7 billion in revenue for 2027, though it did not provide updated guidance for that year. The company emphasized that 2026 guidance does not reflect any impact from the planned Modine combination, which is expected to close in early fourth quarter.
The guidance assumes current tariff structures remain in effect, a EUR/USD exchange rate of $1.16 per euro, and an effective tax rate of approximately 30%. Management noted that third quarter margins are expected to remain pressured before improving in the fourth quarter as inflation recovery timing normalizes and footprint optimization benefits materialize.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.